Hypopigmentation Disorder Treatment Market Analysis, Size, and Share by 2031

Historic Data: 2021-2023   |   Base Year: 2023   |   Forecast Period: 2023-2031

Hypopigmentation Disorder Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Topical Drugs, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, and Others), Disease Indication (Pityriasis Alba, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation, and Others), End User (Aesthetic Clinics, Dermatology Centers, and Hospitals), and Geography

  • Report Date : Aug 2025
  • Report Code : TIPRE00004312
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

[Research Report] Hypopigmentation disorder treatment market value is expected to grow from US$ 4.4 billion in 2023 to US$ 6.7 billion by 2031; the market is estimated to record a CAGR of 5.41% from 2023 to 2031.

Market Insights and Analyst View:

Hypopigmentation disorders may further develop into depigmentation disorders. It is a condition wherein skin pigment levels are below optimum, unlike depigmentation conditions that occur due to the complete removal of pigments. Major factors driving the hypopigmentation disorder treatment market growth are the rising awareness related to hypopigmentation disorders, technological advancements in aesthetic treatments, and a continuous surge in the aging population. Moreover, increasing incidences of disorders related to hypopigmentation, such as albinism, post-hypopigmentation, and vitiligo, are anticipated to fuel the hypopigmentation disorders treatment market in the coming years. Further, growing consumer spending on skin health and awareness related to treatment is predicted to benefit this market in the near future. The introduction of natural and plant-based components is expected to bring hypopigmentation disorder treatment market trends in the coming years, as these products have been critical in meeting the global demand for cosmeceutical products so far. The cost of cosmetic treatments and surgery, on the other hand, restricts the market growth.

According to the National Clinical Trials (NCT) registry, in June 2020, Incyte Corporation conducted a phase II clinical trial for Ruxolitinib to evaluate its safety and efficacy in treating vitiligo in subjects enrolled in the US. Thus, the increasing number of clinical trials associated with hypopigmentation disorders is another key factor bolstering the market.

Growth Drivers and Challenges:

Increasing Prevalence of Hypopigmentary Disorders Propels Market Growth

Pityriasis alba, vitiligo, albinism, and post-inflammatory hypopigmentation are among the major disease indications associated with hypopigmentation disorders. Vitiligo is a commonly occurring disease indication across the world. According to a study published in the Dermatology Practical and Conceptual in December 2023, Vitiligo is a prevalent skin condition affecting both genders. Nonetheless, it is more prevalent in females, and more than 60% of patients experience disease onset before the age of 30. Rising incidences and prevalence of vitiligo are anticipated to further contribute to the growing demand for hypopigmentation treatments.

According to an article published in Zagazig University Medical Journal in March 2023, hypopigmentation disorders are a common group of dermatoses in pediatrics; the prevalence of hypopigmentation disorders varies from country to country, ranging from 3.6% to 9.9%. Furthermore, the advent and adoption of minimally invasive procedures, shorter hospital admittance time, and lesser pain and fewer complications associated with procedures have been pivotal for the growing popularity of minimally invasive procedures. According to the American Society of Plastic Surgeons (ASPS) in 2021, the number of minimally invasive cosmetic procedures performed in the US has surged by nearly 200% since 2000. Thus, the growing preference for minimally invasive cosmetic procedures further propels the hypopigmentation disorder treatment market growth. On the other hand, the cost of light therapy for disease indications such as vitiligo and albinism is high. Moreover, surgical procedures to treat vitiligo procedures are highly expensive. Thus, the high cost of treatments limits their adoption, thereby limiting the growth of the hypopigmentation disorder treatment market.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Hypopigmentation Disorder Treatment Market: Strategic Insights

hypopigmentation-disorder-treatment-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Report Segmentation and Scope:

The hypopigmentation disorder treatment market analysis has been carried out by considering the following segments: treatment, disease indication, and end user. The geographic scope of the hypopigmentation disorder treatment market report includes North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

Treatment-Based Insights

Based on treatment, the market is segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, phototherapy, and others. The topical drugs segment held the largest hypopigmentation disorder treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Disease Indication-Based Insights

Based on disease indication, the hypopigmentation disorder treatment market is segmented into pityriasis alba, albinism, vitiligo, post-inflammatory hypopigmentation, and others. The vitiligo segment held a significant market share by 2023, and it is expected to register the highest CAGR during 2023–2031.

End User-Based Insights

In terms of end user, the market is categorized into aesthetics clinics, dermatology centers, and hospitals. The aesthetics clinics segment held the largest hypopigmentation disorder treatment market share in 2023; it is further anticipated to register the highest CAGR in the market during 2023–2031.

Hypopigmentation Disorder Treatment Market Regional Insights

The regional trends and factors influencing the Hypopigmentation Disorder Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Hypopigmentation Disorder Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

hypopigmentation-disorder-treatment-market-global-geography
  • Get the Regional Specific Data for Hypopigmentation Disorder Treatment Market

Hypopigmentation Disorder Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 4.4 Billion
Market Size by 2031 US$ 6.7 Billion
Global CAGR (2023 - 2031) 5.41%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Treatment
  • Topical Drugs
  • Laser Therapy
  • Chemical Peels
  • Microdermabrasion
  • Phototherapy
By Disease Indication
  • Pityriasis Alba
  • Vitiligo
  • Albinism
  • Post-Inflammatory Hyperpigmentation
By End User
  • Aesthetic Clinics
  • Dermatology Centers
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Allergan
  • SkinCeuticals
  • Pierre Fabre
  • Obagi Cosmeceuticals LLC
  • Incyte
  • Galderma S.A.
  • TeVido BioDevices, Inc.
  • STRATA Skin Sciences
  • AVITA Medical

  • Hypopigmentation Disorder Treatment Market Players Density: Understanding Its Impact on Business Dynamics

    The Hypopigmentation Disorder Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Hypopigmentation Disorder Treatment Market are:

    1. Allergan
    2. SkinCeuticals
    3. Pierre Fabre
    4. Obagi Cosmeceuticals LLC
    5. Incyte

    Disclaimer: The companies listed above are not ranked in any particular order.


    hypopigmentation-disorder-treatment-market-cagr

    • Get the Hypopigmentation Disorder Treatment Market top key players overview

    Regional Analysis:

    North America held the largest share of the hypopigmentation disorder treatment market in 2023, and it is projected to maintain its dominance (in terms of share) during the forecast period. The US dominates the market in this region (with the largest share) and the world. Well-established healthcare infrastructure, rising consciousness among people about their skin health, increasing prevalence of diseases associated with hypopigmentation disorders, and significant presence of companies that provide attractive treatment options for patients with post-inflammatory hyperpigmentation are among the noteworthy factors driving the market growth in North America. Further, beauty concerns with the rising beauty standards among Asians, a large number of companies entering the market, and the continued growth of established players are among the key factors contributing to the expansion of the hypopigmentation disorder treatment market size in Asia Pacific.

    Competitive Landscape and Key Companies:

    The hypopigmentation disorder treatment market forecast can help stakeholders in this marketplace plan their growth strategies. Allergan, SkinCeuticals, Pierre Fabre Group, Incyte Corporation, Episciences Inc., Phio Pharmaceuticals, Obagi Cosmeceuticals LLC, Alvogen, Bella Aurora, AbbVie are a few key companies profiled in the hypopigmentation disorder treatment market report. These companies focus on expanding their product offerings to meet the growing consumer demand across the world. Their global presence allows them to serve many customers.


    Frequently Asked Questions

    What are the growth estimates for the hypopigmentation disorder treatment market till 2031?

    The hypopigmentation disorder treatment market is expected to be valued at US$ 6,750.10 million in 2030.

    Which hypopigmentation disease indication segment dominates the hypopigmentation disorder treatment market?

    Based on disease indication type, the hypopigmentation disorder treatment market is segmented into pityriasis alba, vitiligo, albinism, PIH and others. Vitiligo is anticipated to gain significant traction in the upcoming years. Rising prevalence of vitiligo globally and number of patients suffering from this disease is expected to drive the market growth.

    What was the estimated hypopigmentation disorder treatment market size in 2023?

    The hypopigmentation disorder treatment market was valued at US$ 4,428.57 million in 2023.

    Who are the major players in the hypopigmentation disorder treatment market?

    The hypopigmentation disorder treatment market has major market players, including Allergan, SkinCeuticals, Pierre Fabre, EpiSciences, Incyte, STRATA Skin Sciences, AVITA Medical, Galderma S.A.

    Which treatment type segment dominates the hypopigmentation disorder treatment market?

    Based on type, the topical drugs segment in the hypopigmentation disorder treatment market is expected to record the fastest CAGR from 2023 to 2031. Factor such as ease of convenience of taking these drugs, increasing number of topical drugs to treat hypopigmentary scars.

    What factors drive the hypopigmentation disorder treatment market?

    Growing prevalence of skin diseases and rising demand for affordable and effective treatment solution globally. In 2023, the World Health Organization released estimates that skin diseases impacted over 1.8 million people worldwide. However, the stringent regulatory processes and high cost of hypopigmentation disorder treatment is expected to hinder the growth of the hypopigmentation disorder treatment market.

    What is Hypopigmentation Disorders?

    Hypopigmentation disorders are skin conditions caused due to loss in skin color. These disorders include vitiligo, albinism, and pityriasis alba among other disorders. Treatment depends on the severity of specific disease conditions.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Hypopigmentation Disorder Treatment Market

    1. Allergan
    2. SkinCeuticals
    3. Pierre Fabre
    4. Obagi Cosmeceuticals LLC
    5. Incyte
    6. Galderma S.A.
    7. TeVido BioDevices, Inc.
    8. STRATA Skin Sciences
    9. AVITA Medical
    10. Courage + Khazaka electronic GmbH
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo